Enrolment complete for phase-3 clinical trials of the new Covid-19 vaccine, Covishield in India.

Serum Institute of India (SII) in partnership with ICMR has enrolled around 1,600 participants and will conduct the trial across 15 different centers in India. SII & ICMR have also collaborated for the clinical development of Covovax, a Covid-19 vaccine being developed by the US drug company, Novavax.

https://www.thehindu.com/news/national/covishield-completes-enrolment-of-phase-3-clinical-trials-under-partnership-of-icmr-and-serum-institute-of-india/article33081171.eceSerum Institute of India (SII) in partnership with ICMR has enrolled around 1,600 participants and will conduct the trial across 15 different centers in India.

SII & ICMR have also collaborated for the clinical development of Covovax, a Covid-19 vaccine being developed by the US drug company, Novavax.

Sign Up for NextBigWhat Newsletter

Daily.

You May Also Like